Hematologic response and stabilization of renal function in a patient with light chain deposition disease after lenalidomide treatment: A novel therapeutic approach?

Citation:

Gkotzamanidou M, Terpos E, Kastritis E, Dimopoulos MA. Hematologic response and stabilization of renal function in a patient with light chain deposition disease after lenalidomide treatment: A novel therapeutic approach?. Clinical Lymphoma, Myeloma and Leukemia [Internet]. 2014;14(5):e179 - e181.

Notes:

Export Date: 21 February 2017

Website